Analyst Ratings for Beta Bionics, Inc. (BBNX)
BBNX Rating Summary
BBNX Price Target Summary
- Highest: $30.40 (Ladenburg Thalmann)
- Lowest: $14.00 (Baird)
- Average: $20.31
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.31 (+4.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$20.31 (+4.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/21/2026 | William Blair | Steven Lichtman | New Coverage | Market Perform (N/A) |
N/A (N/A) |
19.48 (19.47) |
-0.05% | Details |
| 7/28/2026 | UBS | Patrick Wood | New Coverage | Buy (N/A) |
22.00 (N/A) |
15.99 (19.47) |
21.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
